Canasa is a brand name of mesalamine, approved by the FDA in the following formulation(s):
CANASA (mesalamine - suppository; rectal)
Manufacturer: AXCAN
Approval date: November 5, 2004
Strength(s): 1GM [RLD]
Has a generic version of Canasa been approved?
No. There is currently no therapeutically equivalent version of Canasa available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Canasa. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
There are no current U.S. patents associated with Canasa.
See also...
- Canasa Suppositories Consumer Information (Wolters Kluwer)
- Canasa rectal Consumer Information (Cerner Multum)
- Canasa Rectal Advanced Consumer Information (Micromedex)
- Mesalamine Controlled-Release Capsules Consumer Information (Wolters Kluwer)
- Mesalamine Delayed-Release Tablets Consumer Information (Wolters Kluwer)
- Mesalamine Enema Consumer Information (Wolters Kluwer)
- Mesalamine Extended-Release Capsules Consumer Information (Wolters Kluwer)
- Mesalamine Suppositories Consumer Information (Wolters Kluwer)
- Mesalamine Consumer Information (Cerner Multum)
- Mesalamine rectal Consumer Information (Cerner Multum)
- Mesalamine Advanced Consumer Information (Micromedex)
- Mesalamine Rectal Advanced Consumer Information (Micromedex)
- SfRowasa Advanced Consumer Information (Micromedex)
- Mesalamine AHFS DI Monographs (ASHP)
No comments:
Post a Comment